Win, Lose & Draw: Third Merck Vioxx Trial Ends In Mistrial
This article was originally published in The Pink Sheet Daily
Executive Summary
A Houston jury was unable to reach a verdict in the first federal product liability trial over the COX-2 inhibitor.